Table 4.
Multivariate survival analyses
| Parameter | Category | DSS | DMeFS | LRFS | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | ||
| Stage | I-II | 1 | - | 0.121 | 1 | - | 0.183 | 1 | 0.037* | |
| III-IV | 1.725 | 0.867-3.431 | 1.642 | 0.791-3.406 | 2.766 | 1.064-7.191 | ||||
| CDKN3 Exp. | Low Exp. | 1 | - | <0.001* | 1 | - | <0.001* | 1 | - | <0.001* |
| High Exp. | 11.999 | 5.378-26.771 | 15.069 | 5.884-38.592 | 5.000 | 2.312-10.815 | ||||
*, Statistically significant; DSS, disease-specific survival; DMeFS, distal metastasis-free Survival; LRFS, local recurrence-free survival; HR, hazard ratio; CI, confidence interval